Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725928 · ClinicalTrials.gov registry record · NA
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
A NA study of Frailty and Mobility Limitation, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 5
- Study locations
NCT05725928: Recruiting NA study of Frailty and Mobility Limitation, sponsored by The Cleveland Clinic.
NCT05725928 is a NA study of Frailty and Mobility Limitation that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 3,000 participants, above the 1,444-participant average among 48 other Frailty trials with a reported enrollment target (108% higher). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05725928, a NA study of Frailty and Mobility Limitation, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
The investigator proposes to conduct a randomized trial of supervised ambulation delivered by mobility technician (MT) up to three times daily, including weekends, to hospitalized medical patients. The aims of the study are to compare the short and intermediate-term outcomes of patients randomized to the intervention versus those patients randomized to receive usual care, to identify patients who are most likely to benefit from the intervention and to assess whether the intervention increases or decreases overall costs of an episode of care, including the cost of the MTs, the index hospitalization and the first 30 days post enrollment.
Primary Outcome
Every patient will have an SPPB score on admission to the study. A blinded assessor will measure the SPPB again at discharge or on day 10 if the patient is still hospitalized. The primary outcome is change from admission to discharge. Investigators will also compare the percentage of patients who reach the minimal clinically important difference of 1 point. SPPB minimum value= 0 SPPB maximum value= 12 (higher score indicates a better outcome). If no blinded team member is available, the evaluat
Conditions Studied
Interventions
- BEHAVIORAL Mobility technician
Study Locations (5)
Ohio
- Fairview Hospital - Cleveland
- Cleveland Clinic- Main Campus - Cleveland
- Marymount Hospital - Garfield Heights
- Hillcrest Hospital - Mayfield Heights
Massachusetts
- Baystate Medical Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2026-10-11 |
| Phase | NA |
What NCT05725928 shows while recruiting
NCT05725928 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,444-participant average among 48 other Frailty trials with a reported enrollment target (108% higher).
The record links to 4 conditions, with Frailty appearing as the primary indexed condition, and to 1 intervention - of which Mobility technician is the first listed.
NCT05725928 lists 5 locations in 2 states (Ohio, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05725928 about?
NCT05725928 is a clinical study titled "Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients". The investigator proposes to conduct a randomized trial of supervised ambulation delivered by mobility technician (MT) up to three times daily, including weekends, to hospitalized medical patients. The aims of the study are to compare the short and intermediate-term outcomes of patients randomized t...
What is the current status of trial NCT05725928?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2023-05-15. Estimated completion is 2026-10-11.
What conditions does trial NCT05725928 study?
This clinical trial studies the following conditions: Frailty, Mobility Limitation, Hospital Acquired Condition, Weakness, Muscle.
What interventions are being tested in trial NCT05725928?
The interventions under investigation include: Mobility technician (BEHAVIORAL).
Who is sponsoring clinical trial NCT05725928?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05725928 being conducted?
This trial has 5 study locations across Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05725928's enrollment target sits among peer trials
3,000 4th of 48 higher than 45 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Meal Delivery and Exercise
RECRUITING · NA
-
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI